IPM Take
The calendar changed. The postcode did not.
England’s revised childhood schedule is doing what policy promised for MenB: protecting babies earlier. But the same release shows the hard truth about immunisation. A better timetable is not the same thing as universal reach. Public health can move an appointment forward by four weeks. It still has to reach every family, in every neighbourhood, before the virus reaches them first.
Executive Summary
UKHSA reported that second-dose MenB coverage among six-month-old babies in England reached 89.8% in April 2026, up 4.6 percentage points from April 2025 after the dose was moved from 16 to 12 weeks of age. The same update showed first-dose MMR/MMRV coverage ranging from 72.0% in London to 83.0% in the South West. England had recorded 801 laboratory-confirmed measles cases from 1 January to 22 June, including two child deaths in 2026. (GOV.UK)
Why it matters
- Public authorities: Need to treat catch-up vaccination as a delivery operation, not an optional communications campaign.
- Clinicians: Need every child-health contact to become an opportunity to identify and close missed-dose gaps.
- Families: Need reminders, flexible appointments and trusted local advice, especially where access or confidence has already been weakened.
The MenB result is real progress. Moving the second dose from 16 to 12 weeks means babies can gain protection a full month earlier in life. It is exactly what a well-run national vaccination programme should do: identify a preventable risk, adjust the pathway, then watch whether the change reaches children in practice. (GOV.UK)
But the same figures tell a less comfortable story. MMR/MMRV first-dose coverage still varies sharply by region. In London, fewer than three in four eligible children had received their first dose by the April measurement point. Meanwhile, 60% of the 801 confirmed measles cases recorded this year were in children aged 10 and under, and London accounted for nearly half of cases reported in the most recent four-week period. (GOV.UK)
This is not a dispute about whether the tools exist. MenB, MMR and MMRV vaccines are already part of routine care. The policy problem is the last mile: finding children who missed a dose, making appointments workable for parents, and ensuring the local clinic, pharmacy or outreach service can act before an outbreak forces the issue.
The human cost sits behind the coverage chart. A missed vaccination may look like a data point until it becomes a frightened parent in an emergency department, a child excluded from school after an exposure, or a baby too young to be vaccinated who depends on the immunity of everyone around them.
For IPM, this is a reminder that timing is only half of precision prevention. The right vaccine at the right age matters. So does the right route to the family who has not yet received it.
